[1] WANG CY,LI F,ZHAO YP,et al. Treatment of acute pancreatitis(2014)[J]. J Clin Hepatol,2015,31(1):17-20.(in Chinese)王春友,李非,赵玉沛,等.急性胰腺炎诊治指南(2014)[J].临床肝胆病杂志,2015,31(1):17-20.
|
[2] CROCKETT SD,WANI S,GARDNER TB,et al. American Gastroenterological Association Institute Guideline on initial management of acute pancreatitis[J]. Gastroenterology,2018,154(4):1096-1101.
|
[3] GULLO L,MIGLIORI M,OLAH A,et al. Acute pancreatitis in five European countries:Etiology and mortality[J]. Pancreas,2002,24(3):223-227.
|
[4] HUANG LB,TANG CW,XIE YM,et al. Risk factors of 3073cases of acute pancreatitis in Chengdu[J]. J Sichuan Univ:Med Sci Ed,2005,36(1):138-139.(in Chinese)黄丽彬,唐承薇,谢咏梅,等.成都地区3073例急性胰腺炎致病危险因素分析[J].四川大学学报:医学版,2005,36(1):138-139.
|
[5] FENG ZD,LIU ZJ. Clinical analysis of early and delayed laparoscopic cholecystectomy for mild acute biliary pancreatitis[J]. Chin J Med Offic,2018,46(2):213-215.(in Chinese)冯章东,刘佐军.早期与延期腹腔镜胆囊切除术治疗轻型急性胆源性胰腺炎临床疗效分析[J].临床军医杂志,2018,46(2):213-215.
|
[6] WU HH. Clinical characteristics and prognosis of acute biliary pancreatitis and acute alcoholic pancreatitis[J]. J Qiqihar Med Coll,2015,36(12):1794-1795.(in Chinese)吴航海.急性胆源性胰腺炎与急性酒精性胰腺炎的临床特点及预后分析[J].齐齐哈尔医学院学报,2015,36(12):1794-1795.
|
[7] YU XE,DENG YH,HUANG PN,et al. Clinical study on alcoholic effect in the severity of acute pancreatitis[J]. Chin J Gastroenterol Hepatol,2015,24(7):875-878.(in Chinese)余贤恩,邓有辉,黄培宁,等.酒精在急性胰腺炎重症化中作用的临床研究[J].胃肠病学和肝病学杂志,2015,24(7):875-878.
|
[8] LI Q,WU PF,XU ZK,et al. Clinical and prognostic analysis of85 cases of alcoholic acute pancreatitis[J]. Jiangsu Med J,2013,39(24):3025-3026.(in Chinese)李强,吴鹏飞,徐泽宽,等.85例酒精性急性胰腺炎的临床与预后分析[J].江苏医药,2013,39(24):3025-3026.
|
[9] ZHAO B. Clinical characteristics and prognosis of acute biliary pancreatitis and acute alcoholic pancreatitis[J]. Mod Diagn Treat,2013,24(13):3058-3059.(in Chinese)赵波.急性胆源性胰腺炎与急性酒精性胰腺炎的临床特点及预后分析[J].现代诊断与治疗,2013,24(13):3058-3059.
|
[10] BANKS PA,BOLLEN TL,DERVENIS C,et al. Classification of acute pancreatitis-2012:Revision of the Atlanta classification and definitions by international consensus[J]. Gut,2013,62(1):102-111.
|
[11] TENNER S,BAILLIE J,DEWITT J,et al. American College of Gastroenterology Guidelines:Management of acute pancreatitis[J]. Am J Gastroenterol,2013,108(9):1400-1415,1416.
|
[12] ZHANG N,ZHANG HY,GUO XH,et al. Changes of etiology in acute pancreatitis in recent 10 years in China:Meta-analysis[J/CD]. Chin J Digest Med Imageol:Electronic Edition,2016,6(2):71-75.(in Chinese)张娜,张海燕,郭晓红,等.中国近十年急性胰腺炎病因变化特点的Meta分析[J/CD].中华消化病与影像杂志:电子版,2016,6(2):71-75.
|
[13] CHEN YT. Investigation of etiology and clinical characteristics of acute pancreatitis in four hospitals in Xi'an[D]. Yinchuan:Ningxia Medical University,2016.(in Chinese)陈依婷.西安市四家医院的急性胰腺炎病因调查及临床特点分析[D].银川:宁夏医科大学,2016.
|
[14] RUAN JG,SUN JL,ZANG Y. Etiology and clinical characteristics of acute pancreatitis[J]. J Ningxia Med Univ,2016,38(7):791-794.(in Chinese)阮继刚,孙金玲,臧媛.急性胰腺炎的病因及临床特征分析[J].宁夏医科大学学报,2016,38(7):791-794.
|
[15] LI ZF,ZHAO Q,WANG B. Analysis of the etiology of acute pancreatitis in Southwest Shandong Province in the past 20years[J]. Chin J Pancreatol,2018,18(6):399-401.(in Chinese)李振方,赵琦,王兵.山东鲁西南地区近20年急性胰腺炎患者病因变化分析[J].中华胰腺病杂志,2018,18(6):399-401.
|
[16] KONG LX,ZHANG JW. Severity and local complications of acute pancreatitis based on etiology[J]. Lab Med Clin,2016,13(9):1209-1210,1213.(in Chinese)孔琳熙,张俊文.急性胰腺炎病因与局部并发症及严重程度的相关性分析[J].检验医学与临床,2016,13(9):1209-1210,1213.
|
[17] STERNBY H,BOLADO F,CANAVAL-ZULETA HJ,et al. Determinants of severity in acute pancreatitis:A nation-wide multicenter prospective cohort study[J]. Ann Surg,2019,270(2):348-355.
|
[18] NESVADERANI M,ESLICK GD,VAGG D,et al. Epidemiology,aetiology and outcomes of acute pancreatitis:A retrospective cohort study[J]. Int J Surg,2015,23(Pt A):68-74.
|
[19] GAPP J,HALL AG,WALTERS RW,et al. Trends and outcomes of hospitalizations related to acute pancreatitis:Epidemiology from 2001 to 2014 in the United States[J]. Pancreas,2019,48(4):548-554.
|
[20] SAMARASEKERA E,MAHAMMED S,CARLISLE S,et al.Pancreatitis:Summary of NICE guidance[J]. BMJ,2018,362:k3443.
|
[21] YADAV D,PAPACHRISTOU GI,WHITCOMB DC. Alcoho-associated pancreatitis[J]. Gastroenterol Clin North Am,2007,36(2):219-238.
|
[22] SATOH K,SHIMOSEGAWA T,MASAMUNE A,et al. Nationwide epidemicological survey of acute pancreatitis in Japan[J]. Pancreas,2011,40(4):503-507.
|
[23] KRISTIANSEN L,GRNBAEK M,BECKER U,et al. Risk of pancreatitis according to alcohol drinking habits:A population-based cohort study[J]. Am J Epidemiol,2008,168(8):932-937.
|
[24] ZHU Y,PAN X,ZENG H,et al. A study on the etiology,severity,and mortality of 3260 patients with acute pancreatitis according to the revised atlanta classification in Jiangxi,China over an 8-year period[J]. Pancreas,2017,46(4):504-509.
|
[25] KIM KO,KIM TN. Acute pancreatic pseudocyst:Incidence,risk factors,and clinical outcomes[J]. Pancreas,2012,41(4):577-581.
|
[26] FAN LY,JIANG YG,KONG XJ,et al. Risk factors analysis for the formation of pancreatic pseudocysts in acute pancreatitis[J]. Chin J Pancreatol,2018,18(1):20-24.(in Chinese)范丽玉,姜英俊,孔心涓,等.急性胰腺炎并发胰腺假性囊肿形成的危险因素分析[J].中华胰腺病杂志,2018,18(1):20-24.
|
[27] CUI ML,KIM KH,KIM HG,et al. Incidence,risk factors and clinical course of pancreatic fluid collections in acute pancreatitis[J]. Dig Dis Sci,2014,59(5):1055-1056.
|
[28] POORNACHANDRA KS,BHASIN DK,NAGI B,et al. Clinical,biochemical,and radiologic parameters at admission predicting formation of a pseudocyst in acute pancreatitis[J]. J Clin Gastroenterol,2011,45(2):159-163.
|
[29] YU XE. Analysis of causes and prognosis of 113 patients with severe acute pancreatitis[J]. Chin J Primary Med Pharm,2012,19(4):526-528.(in Chinese)余贤恩.重症急性胰腺炎113例病因及预后分析[J].中国基层医药,2012,19(4):526-528.
|
[30] RAZVODOVSKY YE. Alcohol consumption and pancreatitis mortality in Russian[J]. JOP,2014,15(4):365-370.
|
[31] XU C,QIAO Z,LU Y,et al. Influence of fatty liver on the severity and clinical outcome in acute pancreatitis[J]. PLo S One,2015,10(11):e0142278.
|
[32] CAI ZZ,LI ZX. Research progress in the pathogenesis of chronic alcoholic pancreatitis[J]. Foreign Medicine(Digestive Diseases),2005,25(6):391-394.(in Chinese)蔡振寨,李兆申.酒精性慢性胰腺炎发病机制研究进展[J].国外医学(消化系疾病分册),2005,25(6):391-394.
|
[33] ZHOU XC,TANG CW,LIU CL. Moderate diet protein intake slows down progression of alcoholic pancreatic acinar cell retrogression[J]. Pancreatology,2006,6(2):69-73.(in Chinese)周旭春,唐承薇,刘纯伦.蛋白质摄入量在酒精性胰腺损伤中的作用[J].胰腺病学,2006,6(2):69-73.
|
[34] ZHAO QL,HUANG CY,LI XM. Study on the mechanism of alcohol induced pancreatitis[J]. Chin J Pancreatol,2007,7(1):49-51.(in Chinese)赵秋玲,黄承钰,李晓明.酒精致胰腺炎的机制研究[J].胰腺病学,2007,7(1):49-51.
|
[1] | Min WANG, Wenping LUO, Guanhua ZHANG, Xinyan ZHAO, Hong MA, Ying TIAN, Yu WANG. Diagnostic value of FibroTouch, FibroScan, and acoustic radiation force impulse for liver fibrosis in patients with primary biliary cholangitis[J]. Journal of Clinical Hepatology, 2021, 37(4): 817-822. doi: 10.3969/j.issn.1001-5256.2021.04.019 |
[2] | Li ZhengXin, Chen YangYi, Zhao ZhiMin, Lyu Jing, Chen GaoFeng, Liu ChengHai. Influencing factors for FibroTouch measurements in chronic hepatitis B patients based on liver pathology[J]. Journal of Clinical Hepatology, 2019, 35(2): 338-344. doi: 10.3969/j.issn.1001-5256.2019.02.019 |
[3] | Leng XueJun, Yan XueBing. Efficiency of FibroTouch in evaluating liver fibrosis degree in nonalcoholic fatty liver disease patients with different levels of body mass index[J]. Journal of Clinical Hepatology, 2018, 34(9): 1891-1895. doi: 10.3969/j.issn.1001-5256.2018.09.013 |
[4] | Li JingBo, Liu Shu, Wen Bo, Gao Nan, Wang BingYuan. Clinical significance of Fibro Touch,ultrasound,and computed tomography in diagnosis of fatty liver disease: a comparative analysis[J]. Journal of Clinical Hepatology, 2016, 32(3): 459-462. doi: 10.3969/j.issn.1001-5256.2016.03.011 |
[5] | Cao HaiYang, Wu XiaoFeng, Lin DongDong. Research advances in fatty donor liver in liver transplantation[J]. Journal of Clinical Hepatology, 2015, 31(7): 1140-1143. doi: 10.3969/j.issn.1001-5256.2015.07.036 |
[6] | Zhang Yu, Cheng Jun. Hepatitis C virus related fatty liver[J]. Journal of Clinical Hepatology, 2015, 31(7): 1034-1037. doi: 10.3969/j.issn.1001-5256.2015.07.009 |
[7] | Wu Na, Zhang MingYuan, Wu RuiHong, Zhang YingWen, Jin JingLan, Zhu YingQiao, Niu JunQi. Diagnostic values of FibroScan and FibroTouch for liver fibrosis: a comparative analysis[J]. Journal of Clinical Hepatology, 2014, 30(7): 624-627. doi: 10.3969/j.issn.1001-5256.2014.07.012 |
[8] | Tang ShaoShan, Zhao GuoJia, Wang YiJiao. Assessment of ultrasound elastography to grade hepatic steatosis in a rat model[J]. Journal of Clinical Hepatology, 2013, 29(4): 282-285. |
[9] | Shi JunPing, Xun YunHao. Progress in treatment of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2013, 29(12): 890-893. doi: 10.3969/j.issn.1001-5256.2013.12.004 |
[10] | Zhou ShuYun, Sun ZheYing. Therapeutic efficacy of polyunsaturated phosphatidylcholine on fatty liver disease[J]. Journal of Clinical Hepatology, 2010, 26(3): 286-287. |
[11] | Xiang GuoQing, Meng XiaoDan, Wang BingYuan. Prevalence of fatty liver among people with different occupation in Shenyang[J]. Journal of Clinical Hepatology, 2010, 26(3): 283-285. |
[12] | Qin YongJun, Sun JieSheng, Wang BingYuan, Liu PengLiang, Sun FuRong, Liu CuiXiang, Xie DaWei. The differences of the blood routine indexes in patients with fatty liver and non-fatty liver[J]. Journal of Clinical Hepatology, 2010, 26(2): 163-166. |
[13] | Xu YuWu, Liu YingZi, Fan JianGao, Yang Lin. Preliminary study on quantification of ultrasonographic classification of fatty liver [J]. Journal of Clinical Hepatology, 2010, 26(3): 267-268+280. |
[14] | Wan Hong, Li Ling, Tang YanPing. study on fatty liver prevalence in the government officers in Lanzhou area[J]. Journal of Clinical Hepatology, 2008, 24(4): 261-262. |
[16] | Hu DeYou. Ultrasonic monitoring of relationship between exercise and fatty liver[J]. Journal of Clinical Hepatology, 2004, 20(1): 34-35. |
[17] | Ding YanHua, He ShuMei, Wang XiaoWei, Xu MaoFeng, Niu JunQi. The clinical feature of 198 patients with fatty liver[J]. Journal of Clinical Hepatology, 2004, 20(5): 287-288. |
1. | 胡馨月,文良志,王斌,魏艳玲,崔红利,陈东风. 2410例肝窦阻塞综合征患者临床特征的系统分析. 胃肠病学和肝病学杂志. 2024(01): 9-14 . ![]() | |
2. | 张万钦,朱芳. 狗舌草致肝窦阻塞综合征. 药物不良反应杂志. 2024(01): 56-58 . ![]() | |
3. | 刘盼盼,陶运生. 乙肝肝硬化合并肝窦阻塞综合征1例. 现代医药卫生. 2024(16): 2877-2880 . ![]() | |
4. | 白婷婷,刘钰懿,陈东风. 肝脏血管性疾病诊断与鉴别诊断. 实用肝脏病杂志. 2023(02): 153-155 . ![]() | |
5. | 李立,罗轶,李丽莉,蒋湘,黄燕红. 白背三七中吡咯里西啶生物碱的含量分析及风险评价. 西北药学杂志. 2023(05): 31-36 . ![]() | |
6. | 贾翠宇,赵大伟,冯骥良,宋文艳,王欣欣. 肝窦阻塞综合征的临床和影像学表现. 临床放射学杂志. 2022(02): 284-288 . ![]() | |
7. | 石玉芝,陈芳,许剑. 土三七致大鼠肝窦阻塞综合征发病机制研究. 现代医学与健康研究电子杂志. 2022(06): 99-103 . ![]() | |
8. | 李宗明,韩新巍,丁鹏绪,周朋利,焦德超,雷钦宇,徐苗. 经颈静脉肝内门体分流术治疗慢性期肝小静脉闭塞症疗效观察. 郑州大学学报(医学版). 2022(03): 422-426 . ![]() | |
9. | 尚亚男,徐浩,郭潇,王仲恺. 土三七致肝窦阻塞综合征的临床及CT特征研究. 医学影像学杂志. 2022(08): 1317-1322 . ![]() | |
10. | 昝珂,周颖,李耀磊,王莹,金红宇,左甜甜,马双成. 赤小豆中吡咯里西啶生物碱氮氧化物含量测定及安全风险评估. 中国药物警戒. 2022(11): 1186-1190 . ![]() | |
11. | 昝珂,蒋黄卉,金红宇,马双成,赵磊,孙艳涛. 中药肝毒性吡咯里西啶生物碱的质量控制研究进展. 药物分析杂志. 2021(04): 572-578 . ![]() | |
12. | 昝珂,周颖,李耀磊,左甜甜,金红宇,王莹,马双成. 罗布麻叶中肝毒性成分吡咯里西啶生物碱的含量分析及其初步风险评估. 中国药事. 2021(07): 757-762 . ![]() | |
13. | 昝珂,周颖,李耀磊,王莹,刘丽娜,金红宇,左甜甜,马双成. UPLC-MS/MS测定一点红不同部位中6种吡咯里西啶生物碱的含量. 中国中药杂志. 2021(17): 4456-4461 . ![]() | |
14. | 昝珂,陈翠玲,周颖,左甜甜,金红宇,王莹,马双成. 马鞭草中6个肝毒性吡咯里西啶生物碱的含量测定及风险评估. 中国实验方剂学杂志. 2021(24): 157-162 . ![]() | |
15. | 李惠贞,蔡剑鸣,董景辉,刘渊,任洪伟,安维民. 肝窦阻塞综合征患者临床及影像学表现分析. 中华消化病与影像杂志(电子版). 2021(06): 263-267 . ![]() | |
16. | 昝珂,李耀磊,周颖,左甜甜,金红宇,王莹,马双成. UPLC-MS/MS法测定大蓟中7个吡咯里西啶生物碱的含量及初步风险评估. 药物分析杂志. 2021(10): 1690-1696 . ![]() | |
17. | 昝珂,周颖,李耀磊,王莹,金红宇,左甜甜,刘丽娜,马双成. 半枝莲中肝毒性成分吡咯里西啶生物碱含量分析及初步风险评估. 药物评价研究. 2021(12): 2608-2613 . ![]() | |
18. | 昝珂,陈翠玲,周颖,金红宇,马双成,王莹. 超高效液相色谱串联质谱法测定木贼中4种吡咯里西啶生物碱. 化学分析计量. 2021(12): 38-42 . ![]() | |
19. | 昝珂,周颖,李耀磊,左甜甜,金红宇,王莹,马双成. 灯盏细辛中吡咯里西啶生物碱的含量分析及其肝毒性风险评估. 中国现代中药. 2021(11): 1897-1901 . ![]() | |
20. | 戚汝平,董景辉,李勇武,安维民,任洪伟,刘渊. 26例肝窦阻塞综合征临床及影像分析. 肝脏. 2020(02): 162-165 . ![]() | |
21. | 徐楠,李江,谢琴秀. 43例吡咯生物碱相关肝窦阻塞综合征临床特征及预后分析. 安徽医学. 2020(07): 797-800 . ![]() | |
22. | 刘少松,周晓东. 吡咯烷生物碱诱导肝窦阻塞综合征的研究进展. 临床内科杂志. 2020(04): 256-259 . ![]() | |
23. | 刘贞利,范作鹏,勾钰淞,柳雅立,张晶. 不同类型肝窦阻塞综合征的临床特征、发病机制与诊治. 临床肝胆病杂志. 2019(01): 208-212 . ![]() | |
24. | 尹昕茹,陈东风. 隐源性肝硬化诊治的临床思维. 医学研究生学报. 2019(06): 576-579 . ![]() | |
25. | 亓传旺,咸建春,肖丽,李阳. 土三七致肝窦阻塞综合征5例临床分析. 中国中西医结合消化杂志. 2019(07): 548-551 . ![]() |